Cited by 93Pharmacogenetics and Drug MetabolismPharmaceutical studies and practicesPharmaceutical Practices and Patient Outcomes

Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate

GREENBLATT, D, HARMATZ, J, VONMOLTKE, L, WRIGHT, C, SHADER, R·2004·Clinical Pharmacology & Therapeutics

Abstract

Sixty-one healthy men and women, aged 20 to 75 years, received single 0.25-mg doses of triazolam, a cytochrome P450 (CYP) 3A substrate benzodiazepine, and placebo in a double-blind crossover study. Among women, age had no significant effect on area under the triazolam plasma concentration curve (AUC) (Spearman r=0.14, P=.44) or clearance (r =-0.09, P=.62). Among men, AUC increased (r=0.43, P <.02) and clearance declined (r=-0.42, P <.02) with increasing age. Gender differences in triazolam kinetics were not apparent. Compared with placebo, triazolam impaired digit-symbol substitution test performance, increased observer-rated sedation, impaired delayed recall of information learned at 1.5 hours after dosing, and increased electroencephalographic beta amplitude. Among men, mean values of relative digit-symbol substitution test decrement (P <.002) and observer-rated sedation (P <.05) were significantly greater in elderly subjects compared with young subjects. Age-dependent differences among women reached significance for observer-rated sedation (P <.02). A combination of higher plasma levels and increased intrinsic sensitivity explained the greater pharmacodynamic effects of triazolam in elderly subjects. Although the findings are consistent with reduced clearance of triazolam in elderly men, individual variability was large and was not explained by identifiable demographic or environmental factors.

Integrity signals

Registry

Crossref · 10.1016/j.clpt.2004.07.009

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Still being checked.

Cited by

Sorted by citations

Authors
GREENBLATT, D., HARMATZ, J., VONMOLTKE, L., WRIGHT, C., & SHADER, R.
Affiliations
Tufts University (US)
Corresponding author
GREENBLATT, D
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2004-11
Volume
76
Issue
5
Pages
467-479
ISSN
0009-9236 (ISSN-L)
OpenAlex
W2125237026
Cited by
93
References
0
Citations by year
2026: 1 · 2025: 2 · 2024: 6 · 2023: 3 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 1 · 2014: 4 · 2013: 7 · 2012: 8
FWCI
6.14
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (AG-17880, R01AG017880)
  • National Institute of Mental Health (MH 58435, R01MH058435)
  • National Institute on Drug Abuse (DA 13834, R21DA013209, R01DA013834, DA 13209, DA05258)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-58435)
  • National Center for Research Resources (RR00054, M01RR000054)
  • National Center for Complementary and Integrative Health (R01AT001381, AT01381)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
triazolam, age effects, gender differences, pharmacokinetics, pharmacodynamics, CYP3A, benzodiazepines, older adults, drug clearance, sedation, cognitive impairment, Digit Symbol Substitution Test, interindividual variability
MeSH terms
Adult, Aged, Aging, Aryl Hydrocarbon Hydroxylases, Double-Blind Method, Electroencephalography, Female, Half-Life, Humans, Hypnotics and Sedatives, Male, Middle Aged, Oxidoreductases, N-Demethylating, Mental Recall, Sex Characteristics, Triazolam, Cross-Over Studies, GABA Modulators, Area Under Curve, Cytochrome P-450 CYP3A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review